Dr. Michal Sheleg joined Pluri in July 2017 and currently holds the position of Vice President of Clinical Development, where she oversees clinical programs, regulatory strategy, and the data department. Prior to her current role, she served as both a Research Manager and Medical Director at Pluri, contributing to the organization’s research and medical initiatives. Dr Sheleg completed her postdoctoral research at the Department of Neurobiology and Ethology in Haifa University. She holds a PhD in Toxicology from the University of Medicine and Dentistry of New Jersey and Rutgers, the State University of New Jersey Joint Graduate Program and holds a BS with Honors in Biology and Mathematics from Saint Peter’s University in NJ.